Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL12818867 | 0.98 | ACHE (0.58) | BCHEACHE | |
| SCHEMBL31207580 | 0.92 | BCHE (0.48) | BCHEACHE | |
| SCHEMBL1396458 | 0.91 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL4642403 | 0.91 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL3997367 | 0.91 | BCHE (0.65) | BCHEACHE | |
| Hydrochloric Acid SCHEMBL8429394 | 0.89 | BCHE (0.62) | BCHEACHE | |
| Hydrochloric Acid SCHEMBL3935134 | 0.89 | BCHE (0.62) | BCHEACHE | |
| SCHEMBL1996136 | 0.85 | BCHE (0.48) | BCHEACHE | |
| Hydrochloric Acid SCHEMBL2834732 | 0.83 | MEN1 (0.46) | BCHEACHE | |
| Bromide SCHEMBL2838215 | 0.83 | ACHE (0.50) | BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022210576-A1 | ADHESIVE AGENT AND ADHERING METHOD | 国立大学法人高知大学 | 2022-10-06 | — | — | WO | disclosed |
| US-20170014533-A1 | DENDRONIZED METALLIC OXIDE NANOPARTICLES, A PROCESS FOR PREPARING THE SAME AND THEIR USES | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2017-01-19 | — | — | US | disclosed |
| US-20160221992-A1 | DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2016-08-04 | — | — | US | disclosed |
| US-20080090816-A1 | ANTI-INFECTIVE BIARYL COMPOUNDS | GENESOFT PHARMACEUTICALS, INC. (US) | 2008-04-17 | — | — | US | disclosed |
| US-7265129-B2 | Anti-infective biaryl compounds | GENESOFT PHARMACEUTICALS, INC. (US) | 2007-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160221992-A1 | DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF | MSR1, CD74, CD4 | BCHE 3330/4885ACHE 2969/4885 |
| US-20080090816-A1 | ANTI-INFECTIVE BIARYL COMPOUNDS | QTRT1, Q6ZSR9, QTRT2 | BCHE 452/4885ACHE 634/4885 |
| US-20170014533-A1 | DENDRONIZED METALLIC OXIDE NANOPARTICLES, A PROCESS FOR PREPARING THE SAME AND THEIR USES | NOXO1, DSTN, NOX3 | BCHE 3768/4885ACHE 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.